Nuclear factor-κB and the pathegenesis of the atherosclerosis

Chinese Pharmacological Bulletin

Volumn 20, Issue 4, 2004, Pages 382-385

  Shi, Cui Ge ^a,b   Hu, Gang ^b   Wang, Hai ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Endothelial cells; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CELL PROTECTION; ENDOTHELIUM CELL; GENE CONTROL; INFLAMMATION; PATHOGENESIS;

EID: 3042577671     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest, 1988;58(3):249-619
2. Osborn L, Hession C, Tizard R et al. Direct expression cloning of vascular cell adhesion molecule I, a cytokine-induced endothelial protein that binds to lymphocytes. Cell, 1989;59(16): 1203-11
3. Elices MJ, Osborn L, Takada Y et al. VCAM-1 on activated endothelium interacts with the leukocyte intergrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell, 1990;60(4):577-84
4. Whelan J, Ghersa P, Van Huijsduijnen RH et al. An NF-κB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1(ELAM-1) gene transcription. Nucleic Acids Res, 1991;19(10):2645-53
5. Crook MF, Neuby AC, Southgate KM. Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture. Atherosclcrosis, 2000;150(4):33-41
6. Lawrence MB, Springer TA. Leukocytes roll on a selection at physiologic flow rates: Distinction form and preequisite for adhesion through intergrins. Cell, 1991;65(5):859-73
7. Brand K, Page S, Rogler G et al. Activiated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest, 1996;97(7):1715-22
8. Collina T. Biology of disease: Endothelial nuclear factor-κB and initiation of atherosclerotic lesion. Lab Invest, 1993;68(5):499-508
9. Li H, Yin H, Zhang H et al. Activation of NF-kappaB and its effects on induction of platelet-derived growth factor-B transcription by angiotensin II in ECV304 cell line. Zhang hua Bing Li Xue Za Zhi, 2001;30(4):276-80
10. Baeuerle PA. The inducible transcription activator NF-kappaB: Regulation by distinct protein subunits. Biochim Biophys Act, 1991;1072(1):63-80
11. Cybulsky MI, Fries JWU, Williams AJ et al. Gene structure, chromosomal location and basis for alternative mRNA splicing of the human VCAM-1 gene. Proc Natl Acad Sci USA, 1991;88(17):7859-63
12. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem, 1992;267(23):16323-9
13. Degitz K, Lian-Jie L, Caughman SW. Cloning and characterization of the 5′-transcription regulatory region of the human intercellular adhesion molecule 1 gene. J Biol Chem, 1991;266 (21):14024-30
14. Collins T. Williams A, Johnston GI et al. Structure and chromosomal location or the gene for endothelial-leukocyte adhesion molecule 1. 1991;266(4):2466-73
15. Ntgomery KF, Osborn L, Hession C et al. Activation of endothelial-leukocyte adhesion molecule I gene transcription. Proc Natl Acad Sci USA, 1991;88(15):6523-7
16. Li D, Chen H, Romeo F et al. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of Lox-1. J Pharmacol Exp Ther, 2002;302(2):601-5
17. Hamuro M, Polan J, Natarajan M, Mohan S. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis, 2002;162(2):277-87
18. Bavendiek U, Libby P, Kilbride M et al. Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B and Egr-1. J Biol Chem, 2002;277(28):25032-9
19. Cooke CL, Davidge ST. Peroxynitrite increases iNOS through NF-kappaB and decreases prostacytin synthase in endothelial cells. Am J Physiol Cell Physiol 2002;282(2):395-402
20. Aoki M, Nata T, Morishita R et al. Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB:Antiapoptosis effect of antioxidant agents on endothelial cells. Hypertension. 2001;38(1):48-55
21. Minekura H, Kumagai T, Kawamoto Y et al. 4-Hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response. Biochem Biophys Res Commun, 2001;282(2):227-61